Global ENT Surgical Devices And Equipment Market

The ENT devices are used in the diagnosis and treatment of ear, nose, and throat diseases. The main types of ENT devices are hearing aid devices and equipment, hearing diagnostic devices and equipment, ENT surgical devices and equipment, hearing implants, voice prosthesis devices and equipment, and nasal splints. A hearing aid device is an electronic device that is worn in or behind the ear. It makes sounds louder so that a person with hearing loss can listen, communicate, and participate fully in daily activities. The type of expenditure is public and private. The products used are instruments/equipment and disposables. The various end-users are hospitals and clinics, diagnostic laboratories, and others. The ENT devices market research report is one of a series of new reports from The Business Research Company that provides ENT devices market statistics, including ENT devices industry global market size, regional shares, competitors with an ENT devices market share, detailed ENT devices market segments, market trends and opportunities, and any further data you may need to thrive in the ENT devices industry. This ENT devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global ent devices market grew from $30.21 billion in 2022 to $32.98 billion in 2023 at a compound annual growth rate (CAGR) of 9.2%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The ent devices market is expected to grow to $45.04 billion in 2027 at a CAGR of 8.1%. Many governments across the world have introduced new healthcare acts and continuously increased healthcare spending. Healthcare coverage and expenditure also increased significantly. In 2021, the Indian government launched Ayushman Bharat PradhanMantri Jan ArogyaYojana (AB-PMJAY) is providing health assurance cover of up to ?5 Lakh per year per family for secondary and tertiary healthcare hospitalizations. Favourable government decisions and increased healthcare spending increased the demand for healthcare services and this drove the demand for ENT devices during this period. Interest rates globally are forecasted to rise in most of the developing and developed economies during the forecast period; this is expected to limit new investments in the market. Most countries across the world are raising interest rates to control inflation and also to limit the flow of capital out of the country. This is likely to affect new investments in terms of expansion, research, and development of new products. For instance, the US interest rates are expected to rise to 3.5% by 2021. These factors are expected to have a negative impact on the market as borrowing money becomes expensive, thereby affecting the market growth. ENT device manufacturers are investing in technologies to develop user-friendly and non-invasive equipment. They are continuously investing funds and resources into R&D to increase the scope of their devices. For instance, Intersect ENT developed Propel Mometasone Furoate Implant (PMFI) to treat chronic sinusitis. It is a bio-absorbable steroid that is placed directly into the sinus mucosa. It controls the release of drugs and dissolves over time. In another breakthrough in sinusitis treatment, SinuSys Corporation received FDA approval for its Vent-Os Sinus Dilation device. It is a small, low-pressure insert that is designed to gently open the sinus ostia and use the body’s natural mucosal fluids to expand the device. Major companies in the ENT devices market include Sonova Holdings AG, William Demant Holdings A/S, Medtronic Inc., GN Store Nord A/S, Cochlear Limited, Olympus Corporation, Stryker Corporation, Karl Storz SE & Co KG, Merck & Co, and Smith & Nephew plc. Asia-Pacific was the largest region in the global ENT devices market in 2022. North America was the second largest region in the global ENT devices market. Africa. was the smallest region in the global ENT devices market. The regions covered in the ENT devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the ENT devices market are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa., South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, and Vietnam. The ENT devices market consists of sales of instruments such as Pure tone and impedance audiometers, BERA and OAE screening machines, nerve stimulators, and high-end microdrill that are used for diagnosis and treatment of ENT diseases. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global ent devices market is segmented - 1) By Type: Hearing Aid Devices And Equipment, Hearing Diagnostic Devices And Equipment, ENT Surgical Devices And Equipment, Hearing Implants, Voice Prosthesis Devices And Equipment, Nasal Splints 2) By End User: Hospitals And Clinics, Diagnostic Laboratories, Other End Users 3) By Type of Expenditure: Public, Private 4) By Product: Instruments/Equipment, Disposables

Nasal splints are devices designed to fit inside or on the nose to provide support after nasal surgery. Nasal splints include intranasal splints and external nasal splints. Intranasal splints are placed into the nose and are used to maintain septal stability and prevent intranasal adhesions following septal surgery. External nasal splints are placed on the outer part of the nose and used to prevent the nose from moving following rhinoplasty or nasal contouring procedures. The main types of nasal splints market are malleable nasal splints, airway nasal splints, and bivalve nasal splints. The bivalve nasal splints are designed to provide septal support and reduce or prevent adhesions between the septum and lateral nasal wall following surgery. The various applications involved are plastic surgery, rhinological operations, ENT surgery, and others. The various end-users are hospitals and clinics, home care, research centres, and others. The nasal splints market research report is one of a series of new reports from The Business Research Company that provides nasal splints market statistics, including nasal splints industry global market size, regional shares, competitors with a nasal splints market share, detailed nasal splints market segments, market trends and opportunities, and any further data you may need to thrive in the nasal splints industry. This nasal splints market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global nasal splints market size will grow from $6.25 billion in 2022 to $6.9 billion in 2023 at a compound annual growth rate (CAGR) of 10.3%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The nasal splints market size is expected to grow to $9.68 billion in 2027 at a CAGR of 8.8%. Rhinoplasty is one of the most commonly performed reconstructive cosmetic surgery across the globe and Rhinoplasty accounted for 62% of the procedures performed on women and 79% of procedures performed on men in 2021. As part of the post-operative procedure, intranasal splints are used to promote hemostasis, structural support and minimize scar formation. Therefore, owing to the rising numbers of rhinoplasty surgery and the use of nasal splints for post-operative care, the market for nasal splints is forecasted to grow. The nasal splints market was limited by a shortage of skilled surgeons and other professionals in most developed and developing countries. Equipment fabrication and integration require specialized skillsets relating to nasal surgeries, and electronics and software. According to a survey conducted by the International Society of Aesthetic Plastic Surgery (ISAPS), in the Middle Eastern countries such as Iran, there were only 238 surgeons to perform 37,423 nose jobs. The specialized skillsets relating to nasal surgeries are available to a limited number of organizations, most of which are located in the USA and Europe. This shortage of skilled surgeons and other professionals is a significant deterrent to the growth of the market. Nasal splints made from biodegradable materials are gaining popularity in the industry, as they do not require surgical removal after implantation. The biodegradable materials in nasal splints include plant-based and bioresorbable materials. They help in controlling bleeding after surgery or nasal trauma, eliminating the need for painful nasal packing removal for patients, and act as an adjunct to aid in the natural healing process. For instance, Smith & Nephew offers a dissolvable nasal splint Nasastent composed of plant-based carboxymethyl cellulose that helps to support the soft nasal tissue and provides pressure to prevent bleeding. This implant eventually converts into a hydro colloidal gel after absorbing nasal fluid and drains from the patient naturally. Some of the other companies offering biodegradable nasal splints are Hemostasis LLC., Medtronic and others. As per the US FDA, nasal splints are classified as Class I medical devices that are exempted from premarket notification. However, nasal splint manufacturers must register their establishment and list the generic category or classification name. Major players in the nasal splints market are Boston Medical Products Inc., Innovia Medical LLC., Medtronic PLC., Olympus Corporation, Smith & Nephew, DTR Medical, Mentor Worldwide LLC., Network Medical Products, Summit Medical Group, and Surgiform Technologies LLC. Asia-Pacific was the largest region in global nasal splints market in 2022. North America was the second-largest region in the nasal splints market. The regions covered in the global nasal splints market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the nasal splints market are Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, the UK, the USA, and Australia. The nasal splints market consists of sales of instruments such as malleable nasal splints, airway nasal splints, and bivalve nasal splints. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global nasal splints market is segmented - 1)By Type: Malleable Nasal Splints, Airway Nasal Splints, Bivalve Nasal Splints, 2) By End User: Hospitals & Clinics, Homecare, Research Centers, Other End Users 3) By Application: Plastic Surgery, Rhinological operations, ENT-Surgery, Other Applications 4) By Route of Administration: Intranasal Segment, Extranasal Segment

Nasal polyps are soft, painless, noncancerous growths on the lining of your nasal passages or sinuses. They dangle like grapes or teardrops and are linked with asthma, persistent infections, allergies, medication sensitivity, and other immunological disorders. The nasal polyps treatment market consists of sales of nasal polyps treatment by entities (organizations, sole traders, and partnerships) that are used for the treatment of nasal polyps which shrink or disrepair the nasal polyps. Nasal polyps are soft, painless noncancerous growths on the lining of your nasal passages or sinuses. They dangle like grapes or teardrops and are linked with asthma, persistent infection, allergies, medication sensitivity, and other immunological disorders. The main types of nasal polyps treatment are pharmacological therapies and surgeries. Pharmacological therapies refers to the use of medication to treat a disorder or disease. In the treatment of addiction, medications are used to reduce withdrawal symptoms, decrease alcohol and other drug cravings, and reduce the likelihood of relapse. The various routes nasal polyps treatment administration include oral, nasal, and others. These are distributed among hospital pharmacies, retail pharmacies, and online pharmacies. The nasal polyps treatment market research report is one of a series of new reports from The Business Research Company that provides nasal polyps treatment market statistics, including nasal polyps treatment industry global market size, regional shares, competitors with a nasal polyps treatment market share, detailed nasal polyps treatment market segments, market trends and opportunities, and any further data you may need to thrive in the nasal polyps treatment industry. This nasal polyps treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global nasal polyps treatment market size grew from $4.36 billion in 2022 to $4.72 billion in 2023 at a compound annual growth rate (CAGR) of 8.2%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The nasal polyps treatment market size is expected to grow to $6.35 billion in 2027 at a CAGR of 7.7%. Developing novel approaches for the treatment of nasal polyps is expected to drive the nasal polyps treatment market going forward. Nasal polyps are a multifactorial syndrome that's linked to a variety of diseases and pathogenic disorders, including allergies, infections, allergic fungal sinusitis, cystic fibrosis, asthma, and aspirin intolerance. Hence, pharmaceutical companies are developing new and novel approaches for its treatment. For instance, in July 2020, GlaxoSmithKline plc (GSK), a UK-based pharmaceutical and biotechnology company, announced that IL-5-targeting monoclonal antibody Nucala (mepolizumab) has been approved by the US Food and Drug Administration (FDA) as a treatment for people with chronic rhinosinusitis with nasal polyps. Adult patients who did not reacted well to nasal corticosteroids used mepolizumab as a maintenance treatment for CRSwNP. Therefore, the development of novel approaches for the treatment of nasal polyps is expected to boost demand for the nasal polyps treatment during the forecast period. New product innovation is a key trend gaining popularity in nasal polyps treatment. Major companies operating in the nasal polyps treatment market are focusing on new product innovations to strengthen their position in the market. For instance, in July 2021, GlaxoSmithKline PLC., a UK-based pharmaceutical company, announced the approval for Nucala (mepolizumab) by US Food and Drug Administration (FDA). Nucala (mepolizumab) is a monoclonal antibody that targets interleukin-5 (IL-5) and is a treatment for patients with chronic rhinosinusitis and nasal polyps. This new indication for mepolizumab is for the maintenance treatment of CRSwNP in adult patients aged 18 and up who have not responded to nasal corticosteroids. In September 2021, Merck & Co. Inc., a US-based biopharmaceutical company, acquired Acceleron Pharma Inc. for a deal amount of $11.5 billion. With this acquisition, Acceleron researchers aim to leverage decades of scientific expertise in the biology of the TGF-beta superfamily to create a powerful biotechnology product. Acceleron is a US-based biopharmaceutical company dedicated to the discovery, development, and commercialization of therapeutics to treat serious and rare diseases including nasal polyps treatment therapies. Major players in the nasal polyps treatment market are Sanofi S.A., GlaxoSmithKline PLC, F. Hoffmann La Roche AG, Merck & Co. Inc., Teva Pharmaceutical Industries Ltd., Novartis International AG, OptiNose US Inc., Regeneron Pharmaceuticals Inc., Intersect ENT Inc., and AstraZeneca PLC. North America was the largest region in the nasal polyps treatment market in 2022 Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nasal polyps treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the nasal polyps treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The nasal polyps treatment market includes revenues earned by entities by nasal corticosteroids, oral and injectable corticosteroids, and other medications. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.  The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global nasal polyps treatment market is segmented - 1) By Type: Pharmacological Therapies, Surgeries 2) By Route: Oral, Nasal, Other Routes 3) By Distribution: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies 

Hearing aids are devices and equipment that are designed and developed to improve the hearing of people affected by hearing loss. The main products of hearing aid devices and equipment are receiver-in-the-ear hearing aids and behind-the-ear hearing aids. A hearing aid receiver works as the ears’ speaker system. It plays the amplified sounds received from the microphone in your ear, and the brain gives the context of the sound. The patients are adults and children. Adult and pediatric patients with conductive hearing loss and sensorineural hearing loss are treated using technologies such as conventional hearing aids and digital hearing aids. The distribution channels are audiology and ENT clinics, pharmacies, online sales, and others. The hearing aid devices and equipment market research report is one of a series of new reports from The Business Research Company that provides hearing aid devices and equipment market statistics, including hearing aid devices and equipment industry global market size, regional shares, competitors with a hearing aid devices and equipment market share, detailed hearing aid devices and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the hearing aid devices and equipment industry. This hearing aid devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global hearing aid devices and equipment market size will grow from $10.21 billion in 2022 to $10.9 billion in 2023 at a compound annual growth rate (CAGR) of 6.7%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The hearing aid devices and equipment market size is expected to grow from $13.97 billion in 2027 at a CAGR of 6.4%. The growing prevalence of hearing loss is a major driver for hearing aid devices & equipment market growth. In the United States, more than 35 million children and adults have some degree of hearing loss. Also, around 900 million people across the globe are expected to suffer from hearing disabilities by 2050 due to the rise in noise pollution levels, genetic factors, ear infections, and other complications. A high number of people suffering from hearing loss would result in huge demand for hearing aid devices across the globe. The high cost of hearing aid devices is acting as a major restraint in the hearing aid devices and equipment market. Good quality hearing aids come at a high price and are not fully covered by insurance companies. About one-third of Americans above 55 years use hearing aid devices due to various reasons. Hearing aid devices range between $1500 to $3500 per piece, thus making them quite expensive. The average price is $2,300 per unit according to the President’s Council for Science & Technology. Thus due to high cost, there has been low penetration of hearing aid devices in the market. The use of 3D Printing is a trend that is prevalent in the hearing aid devices & equipment market. 3D printing is a technology that produces 3D objects from the 2D models which enable the manufacturing of better fitting, more comfortable, and customized hearing aid devices. The 3D printing enables the shape of the ear shell to be customized according to the customer's ear canal and degree of hearing loss. For example, Sonova uses advanced 3D printing technology to produce customized hearing aid devices especially suited for each customer's specific requirements. Examples of 3D hearing aid devices include EnvisionTEC’s E-Shell 200 Series, E-Shell 300 3D Printer Material series, and EnvisionTEC E-Clear series. As of today, the hearing aids fall under the restricted devices category, the sales of these restricted devices must comply with federal and state requirements. The US FDA approach to improve hearing aid accessibility may lead to the availability of these restricted devices as OTC devices. However, according to the FDA Reauthorization Act (FDARA), the category of OTC hearing aids needs to be established and no manufacturer can label their devices as OTC until a separate category is established. Thus, the introduction of these innovative and easily accessible OTC hearing aids may impact the growth of the hearing aid devices market positively in the forecast period. Major players in the hearing aid devices and equipment market are Starkey, Sonova, Widex, Siemens, GN ReSound, Oticon, Unitron, Hansaton, William Demant, and Beltone Asia-Pacific was the largest region in global hearing aid devices and equipment market in 2022. North America was the second-largest region in the hearing aid devices and equipment market. The regions covered in the global hearing aid devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the hearing aid devices and equipment market are Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, the UK, the USA, and Australia. The hearing aid devices and equipment market consists of sales of in-the-ear-hearing aid, receiver-in-the-ear hearing aid, behind-the-ear hearing aid, and canal hearing aids. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global hearing aid devices and equipment market is segmented - 1) By Product: Receiver-In-The-Ear Hearing Aids, Behind-The-Ear Hearing Aids 2) By Distribution Channel: Audiology and ENT Clinics, Pharmacies, Online Sales, Other Distribution Channels 3) By Technology: Conventional Hearing Aid, Digital Hearing Aid 4) By Patient: Adult, Pediatrics 5) By Type of Hearing Loss: Conductive Hearing Loss, Sensorineural Hearing Loss

Hearing diagnostic devices and equipment are used for testing and evaluating hearing loss. These devices usually consist of an embedded hardware unit connected to a pair of headphones and a test subject feedback button, sometimes controlled by a standard personal computer. The main types of hearing diagnostic devices and equipment are otoacoustic emission (OAE), audiometer, otoscope, tympanometer, and others. Otoacoustic emissions (OAEs) are sounds of cochlear origin that are recorded by a microphone fitted into the ear canal. These are used for indications such as conductive hearing loss, sensorineural hearing loss, and combination hearing loss. The end-users involved are hospitals, clinics, personal use, and ambulatory care settings. The hearing diagnostic devices and equipment market research report is one of a series of new reports from The Business Research Company that provides hearing diagnostic devices and equipment market statistics, including hearing diagnostic devices and equipment industry global market size, regional shares, competitors with a hearing diagnostic devices and equipment market share, detailed hearing diagnostic devices and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the hearing diagnostic devices and equipment industry. This hearing diagnostic devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global hearing diagnostic devices and equipment market size will grow from $1.97 billion in 2022 to $2.2 billion in 2023 at a compound annual growth rate (CAGR) of 11.7%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The hearing diagnostic devices and equipment market size is expected to grow from $3.23 billion in 2027 at a CAGR of 10.1%. Growth in the hearing diagnostic and equipment market is attributed to the increasing number of hearing loss cases. This increased prevalence of hearing loss is due to noise pollution, hearing diseases, ototoxic medications, hereditary disorders, birth complications, and a rising geriatric population. According to World Health Organization (WHO), the hearing diagnostic device market is expected to make enormous advancements and investments in hearing diagnostic devices and equipment even as the number of affected individuals is expected to increase to 900 million by 2050 in the world. According to the National Institute on Deafness and Other communication, disorders states that approximately one in three people in the United States between the ages of 65 and 74 have hearing loss, and half of those older than 75 have difficulty hearing. Hence, the rising prevalence of hearing disorders and losses drives the hearing diagnostic devices and equipment market. The unaffordability of healthcare equipment in middle-income countries acts as a major factor hindering the development of the hearing diagnostic device and equipment market. The hearing diagnostic device and equipment market includes advanced technologies and devices for diagnosis, testing, and evaluating hearing loss. The financial inability of remote regions within these middle-income countries, lack of proper infrastructure and healthcare services may hinder the market growth. According to World Bank data, out of the total world population of 7 billion, 5 billion belong to middle-income countries. The hearing healthcare industry is evolving with continuous innovations in terms of technologies used. These technologies use modules like Transient evoked otoacoustic emissions (TEOAE), Distortion product otoacoustic emissions (DPOAE), and Auditory Brainstem Response (ABR). TEOAE is the module that is used for hearing diagnosis and are generated by reflection of traveling wave. DPOAE is used to track the progress of cochlear function in newborns. The ABR is another test used by audiologists to check the way hearing nerves of babies respond to sounds. For example, Maico has invested and recently launched a new product named easy screen with BERAphone that is a combination of ABR, TEOAE, and DPOAE that are used for response detection, reduces the workload, and test time. The European Commission adopted two new regulations for medical devices to enhance safety, take effective measures in the event of concerns, and improve traceability. These regulations provide the medical device manufacturers with a stronger mandate for assessment of medical devices by independent notified bodies, a unique identification number for improving traceability throughout the supply chain, availability of clinical data on devices, and provides a central database to provide patients, healthcare professionals and the public with comprehensive information on products. These rules will help manufacturers to meet the standards, safety requirements and to make better-informed decisions. Major players in the hearing diagnostic devices and equipment market are Natus Medical, Maico Diagnostics, Inventis, William Demant, Amplivox, Welch Allyn, Grason Stadler, Interacoustics, Rion, and Sivantos. North America was the largest region in the global hearing diagnostic devices and equipment market in 2022. Asia-Pacific was the second largest market in hearing diagnostic devices and equipment market. The regions covered in the global hearing diagnostic devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the hearing diagnostic devices and equipment market are Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, the UK, the USA, and Australia. The hearing diagnostic devices and equipment market consists of sales of otoacoustic emission (OAE), audiometer, otoscope, tympanometer, and other hearing diagnostic devices that are used for testing and evaluating the hearingloss. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global hearing diagnostic devices and equipment market is segmented - 1) By Type: Otoacoustic emission (OAE), Audiometer, Otoscope, Tympanometer, Other Types 2) By Indication: Conductive Hearing Loss, Sensorineural Hearing Loss, Combination Hearing Loss 3) By End User: Hospitals, Clinics, Personal Use, Ambulatory care settings

Hearing implants are surgically installed devices aimed at improving the hearing capability of a person suffering from severe or profound levels of hearing loss. The main types of hearing implants devices and equipment are cochlear implants, middle ear implants, bone conduction implants, and auditory brainstem implants. A cochlear implant is an electronic device that partially restores hearing. It is an option for people who have severe hearing loss from inner-ear damage and are no longer helped by using hearing aids. These are used by age groups such as adults and pediatrics. The various end-users are hospitals, ENT clinics, and ambulatory surgical centres. The hearing implants devices and equipment market research report is one of a series of new reports from The Business Research Company that provides hearing implants devices and equipment market statistics, including hearing implants devices and equipment industry global market size, regional shares, competitors with a hearing implants devices and equipment market share, detailed hearing implants devices and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the hearing implants devices and equipment industry. This hearing implants devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global hearing implants market size will grow from $3.95 billion in 2022 to $4.4 billion in 2023 at a compound annual growth rate (CAGR) of 11.3%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The hearing implants market size is expected to grow to $6.36 billion in 2027 at a CAGR of 9.7%. The aging population is increasing worldwide and loss of hearing is one of the most common age-related disorders in the aged above 60 years. As reported by United Nations, in 2020, there are 727 million people aged 65 years in the world and with the increasing geriatric population, the demand for hearing implants is expected to rise. Therefore, the increasing aging population is expected to drive the market for hearing implants in the future. The surgical procedure for implanting hearing implants is associated with various risks and is expected to restraint the market growth in the future. During the surgery, there are possibilities of facial nerve damage which can lead to complete or partial paralysis on the same side of the face as the implant. Due to this and other complications such as the development of meningitis, cerebrospinal fluid leakage, infection, and others, people prefer conventional hearing aids over implants. Hence, restraining the growth of the hearing implants market. Companies in the hearing implants market are making implants using 3D printing in binaural cochlear surgeries. The technology focuses on developing customized 3D printed implants using biocompatible materials to treat anatomical defects with the help of stem cells. Sonova manufactures binaural cochlear implants, which use two different modes of stimulation, electrical and acoustic to enhance hearing and better discrimination of speech. Further, in 2020, scientists developed a 3D-microscaffold cochlear implant using a 3D printed steroid reservoir was designed to reduce the damage of residual hearing against electrode insertion trauma. Cochlear implant manufacturers have to submit information regarding the material used, efficacy based on clinical trials, any adverse effects to the FDA. The manufacturer can begin the sale of the implants in the USA only after receiving approval from the FDA. Major players in the hearing implants devices and equipment market are Sonova (Switzerland), Advanced Bionics AG (Switzerland), Siemens AG, William Demant Holding Group (Denmark), Microson S.A. (Spain), RION, SeboTek Hearing Systems, Arphi Electronics, Widex A/S, and Audina Hearing Instruments. North America was the largest region in the global hearing implants devices and equipment market in 2022. Asia-Pacific was the second-largest region in the hearing implants devices and equipment market. The regions covered in the global hearing implants devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the hearing implants devices and equipment market are Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, the UK, the USA, and Australia. The hearing implants market consists of sales of cochlear implants, bone anchored hearing aids (BAHA), mid-ear implants, and auditory brainstem implants (ABI) that are used to improve hearing capability. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global hearing implants market is segmented - 1) By Type: Cochlear Implants, Middle Ear Implants, Bone Conduction Implants, Auditory Brainstem Implant 2) By End-User: Hospitals, ENT clinics, Ambulatory Surgical Centres 3) By Age: Adult , Pediatric

The laryngoscope is a medical device used to view and examine the larynx and vocal cords in the throat. This device is also used during tracheal intubation in patients requiring ventilator support. The main types of the laryngoscope market are indirect laryngoscope and direct laryngoscope. The direct laryngoscope is the procedure that allows visualization of the larynx during general anesthesia, surgical procedures. The various product involved is video laryngoscopes, standard laryngoscopes, and fiber-optic laryngoscopes. The various end-users are hospitals, clinics, and medical examination centers. The laryngoscope market research report is one of a series of new reports from The Business Research Company that provides laryngoscope market statistics, including laryngoscope industry global market size, regional shares, competitors with a laryngoscope market share, detailed laryngoscope market segments, market trends and opportunities, and any further data you may need to thrive in the laryngoscope industry. This laryngoscope market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global laryngoscope market grew from $0.25 billion in 2022 to $0.28 billion in 2023 at a compound annual growth rate (CAGR) of 11.1%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The laryngoscope market is expected to grow from $0.41 billion in 2027 at a CAGR of 10.0%. The growing prevalence of laryngeal cancers, infections, and chronic respiratory diseases are one of the key reasons expected to boost laryngoscope market growth. Laryngeal cancer is head and neck cancer that occurs when abnormal (malignant) cells form in the larynx. In2020, approximately 99,840 people died of laryngeal cancer worldwide. Moreover, in 2020, in the United States, there were 12,370 new cases and 3,750 deaths from laryngeal cancer. Therefore, the increasing prevalence of laryngeal cancer increased the demand for laryngoscopes and thereby contributed to market growth. Soft tissue injury caused by a laryngoscope is a restraining factor for the laryngoscope market. The most common complication is an injury to the soft palate, although injuries also occur to the teeth, larynx, tongue, and retromolar trigone. The oropharynx is specifically at risk of injury because the video laryngoscope causes the tonsillar pillars to elevate and stretch anteriorly, making them more prone to injury as the tube is being advanced. The soft tissue damage in traditional laryngoscopy is caused mainly by insertion of the laryngoscope, but soft tissue injury with the video laryngoscope is caused by insertion of the endotracheal tube (ETT) itself, as it is often designed blindly into and through the oral cavity and pharynx until it is finally in view at the video laryngoscope monitor. The complications caused demand for a better device, restraining the laryngoscope market. Robot-assisted laryngoscopy is one of the key trends shaping the laryngoscope market. Growing complications or risks associated with advanced and experimental procedures contribute to increased demand for robot-assisted laryngoscopy. The characteristics of robot-assisted devices such as reliability will increase precision levels and have near-absolute geometric accuracy, which helps to reduce the workload of the specialists and improve patient care. Implementing robotic systems leads to faster skill development than manual procedures, and also improves performance and safety. Johns Hopkins University developed a robotic tool to improve surgeons' access to the larynx (voice box). The experts are designing a robotic laryngoscope that can be used with one hand like a joystick. Major players in the laryngoscope market are Ambu, Hill-Rom Holdings, Inc., KARL STORZ, Medtronic, Olympus, HOYA, Roper Technologies, Inc. (Verathon, Inc.), Richard Wolf GmbH, Schoelly Fiberoptic GmbH, and Welch Allyn Inc. Asia-Pacific was the largest region in the laryngoscope market in 2022. North America was the second largest region in the global laryngoscope market. Eastern Europe was the smallest region in the global laryngoscope market. The regions covered in the global laryngoscope market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the laryngoscope market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The laryngoscope market consists of sales of fiber optic laryngoscopes, video laryngoscopes, and standard/conventional laryngoscopes. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global laryngoscope market is segmented - 1) By Type: Indirect Laryngoscope, Direct Laryngoscope 2) By Product: Video Laryngoscopes, Standard Laryngoscopes, Fiber-optic Laryngoscopes 3) By End-user: Hospitals, Clinics, Medical Examination Center

Medical equipment are devices that can be instrument, apparatus or machine that can be used in the prevention, diagnosis or treatment of illness or disease, or for detecting, measuring, restoring, correcting or modifying the structure or function of the body for health purpose. The main types of medical equipment are in-vitro diagnostics, dental equipment and supplies, ophthalmic devices, diagnostic imaging equipment, cardiovascular devices, hospital supplies, surgical equipment, orthopedic devices, patient monitoring devices, diabetes care devices, nephrology and urology devices, ENT devices, anesthesia and respiratory devices, neurology devices, and wound care devices. In-vitro diagnostics are tests done on samples like blood or tissue that is taken from the human body. In-vitro diagnostics will detect diseases or other conditions and are used to monitor a person’s overall health to cure, treat, or prevent diseases. The type of expenditure involved is public and private. The various product are instruments/equipment and disposables. The various end users involved are hospitals and clinics, homecare, diagnostics centres, and others. The medical equipment market research report is one of a series of new reports from The Business Research Company that provides medical equipment market statistics, including medical equipment industry global market size, regional shares, competitors with a medical equipment market share, detailed medical equipment market segments, market trends and opportunities, and any further data you may need to thrive in the medical equipment industry. This medical equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global medical equipment market grew from $639.75 billion in 2022 to $695.05 billion in 2023 at a compound annual growth rate (CAGR) of 8.6%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The medical equipment market is expected to grow to $922.39 billion in 2027 at a CAGR of 7.3%. The rise in sedentary jobs, busy lifestyles, and changing consumer preferences are affecting the disease profile of the world population, especially non-communicable diseases such as cancer, diabetes, and cardiovascular diseases. Long working hours, less physical activity, and unhealthy eating and drinking habits are major causes of chronic diseases such as diabetes. According to the World Health Organization, chronic disease prevalence is expected to rise by 57% globally, by the year 2020. This is increasing the demand for medical devices used in the diagnosis, prognosis, and treatment of several diseases, thereby driving the demand for medical equipment. These factors are expected to increase the patient pool globally, thereby driving the market during the forecast period. Regulatory changes are likely to lead to increased costs relating to new product development and service offerings to clients. These changes are related to customer data protection such as the European Union's General Data Protection Regulation (GDPR), changes to equipment approval procedures, and other regulatory changes. For instance, according to cookieyed data 2021, in the US, PwC reported that 68% of 200 businesses surveyed intended to spend between $1 million and $10 million to comply with GDPR regulations. The GDPR regulation is an EU law on data protection and privacy of individuals residing in the European Union and the European Economic Area (EEA). It also regulates the export of personal data outside the EU and EEA areas. Additionally, the FDA is requesting more clinical data to support claims, therefore increasing the time to process 510(k)s by over 55% over the last decade. The potential loss of revenue due to delays in product release and additional costs incurred due to stringent approval processes puts a strain on investments relating to new product development, thereby affecting the growth of the medical equipment market. Device performance and patient data are available to healthcare service providers and are helping them to improve patient monitoring and overall care quality. Some companies are integrating medical device data with EMR (Electronic Medical Records) to improve transparency and collaboration. As consumer wearables are becoming more common, patient data volumes are increasing and companies are investing in deploying data management, warehousing, and security technologies. For example, Medtronic launched a tool to augment their cardiac devices to securely transfer device data to doctors and allow them to monitor the critical health indicators of their patients. Major companies in the medical equipment market include Medtronic Inc., Abbott Laboratories, Johnson & Johnson, Cardinal Health, Inc., Becton Dickinson, Siemens AG, STRYKER CORPORATION, Koninklijke Philips N.V., F. Hoffmann-La Roche Ltd., and Boston Scientific Corporation. North America was the largest region in the global medical equipment market in 2022. Asia-Pacific was the second largest region in the global medical equipment market. The regions covered in the medical equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the medical equipment market are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa., South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, and Vietnam. The medical equipment market consists of sales of devices used in the diagnosis, treatment and monitoring of medical conditions. The market includes diagnostic devices, imaging devices, surgical devices and patient monitoring devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global medical equipment market is segmented - 1) By Type: In-Vitro Diagnostics, Dental Equipment And Supplies, Ophthalmic Devices, Diagnostic Imaging Equipment, Cardiovascular Devices, Hospital Supplies, Surgical Equipment, Orthopedic Devices, Patient Monitoring Devices, Diabetes Care Devices, Nephrology And Urology Devices, ENT Devices, Anesthesia And Respiratory Devices, Neurology Devices, Wound Care Devices 2) By Type of Expenditure: Public, Private 3) By Product: Instruments/Equipment, Disposables 4) By End User: Hospitals And Clinics, Homecare, Diagnostics Centers, Other End Users Subsegments Covered: Point-of-Care Diagnostics Devices And Equipment, Immunochemistry Diagnostic Devices And Equipment, Clinical Chemistry Diagnostics Devices And Equipment, Molecular Diagnostics Devices And Equipment, Microbiology Diagnostic Devices And Equipment, Hemostasis Diagnostic Devices And Equipment, Hematology Diagnostic Devices And Equipment, Immunohematology Diagnostic Devices And Equipment, Therapeutic Dental Equipment, General Dental Devices And Equipment, Dental Diagnostic Imaging Devices And Equipment, Dental Surgical Devices And Equipment, Vision Care Devices And Equipment, Cataract Surgery Devices And Equipment, Refractive Surgery Devices And Equipment, Diagnostic And Monitoring Ophthalmic Devices And Equipment, X-Ray Systems Devices And Equipment, Ultrasound Systems Devices And Equipment, Computed Tomography (CT) Scanners Devices And Equipment, Magnetic Resonance Imaging Systems Devices And Equipment, Cardiovascular Monitoring And Diagnostic Devices And Equipment, Nuclear Imaging Devices And Equipment, Cardiovascular Surgery Devices And Equipment, Cardiac Rhythm Management (CRM) Devices And Equipment, Interventional Cardiology Devices And Equipment, Defibrillator Devices And Equipment, Peripheral Vascular Devices And Equipment, Prosthetic Heart Valve Devices And Equipment, Electrophysiology Devices And Equipment, Cardiac Assist Devices And Equipment, Disposable Hospital Supplies, Sterilization Equipment And Disinfectants, Mobility Aids And Transportation Equipment, Operating Room Equipment, Surgical Sutures And Staples, Handheld Surgical Devices And Equipment, Electrosurgical Devices And Equipment, Joint Reconstruction Devices And Equipment, Spinal Surgery Devices And Equipment, Trauma Fixation Devices And Equipment, Orthobiologics Devices And Equipment, Arthroscopy Devices And Equipment, Orthopedic Braces And Support Devices And Equipment, Craniomaxillofacial (CMF) Devices And Equipment, Orthopedic Prosthetics, Orthopedic Accessories,, Fetal And Neonatal Monitoring Devices, Weight Monitoring And Body Temperature Monitoring Devices And Equipment, Vital Parameter Monitoring Devices And Equipment, Remote Patient Monitoring Devices And Equipment, Blood Glucose Test Strips, Insulin Pens, Syringes, Pumps And Injectors, Lancing Devices And Equipment, Continuous Glucose Monitoring Devices And Equipment, Blood Glucose Meters, Dialysis Devices And Equipment, Urinary Stone Treatment Devices And Equipment, Urinary Incontinence & Pelvic Organ Prolapse Devices And Equipment, Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment, Endoscopy Devices And Equipment, Hearing Aid Devices And Equipment, Hearing Diagnostic Devices And Equipment, ENT Surgical Devices And Equipment, Hearing Implants, Voice Prosthesis Devices And Equipment, Nasal Splints, Respiratory Devices And Equipment (Therapeutic And Diagnostic), Anesthesia Machines, Anesthesia Disposables, Respiratory Disposables, Cerebrospinal Fluid Management (CSF) Devices And Equipment, Interventional Neurology Devices And Equipment, Neurosurgery Devices And Equipment, Neurostimulation Devices, Traditional Adhesive Dressings, Negative-pressure Wound Therapy (NPWT), Traditional Gauze Dressings, Advanced Wound Care Devices